Today: 29 June 2026
Browse Category

NYSE:EFX 3 October 2025 - 21 October 2025

Equifax Stock Jumps as Earnings Beat Forecasts – Guidance Hiked, Analysts See Upside

Equifax Stock Jumps as Earnings Beat Forecasts – Guidance Hiked, Analysts See Upside

Equifax reported Q3 adjusted earnings of $2.04 per share, beating estimates, with revenue at $1.55 billion. The company raised its full-year outlook and boosted its free cash flow target. Shares traded near $231 ahead of Oct. 21, up slightly after earnings but down 15% over the past year. Equifax also unveiled a new mortgage credit score pricing strategy to undercut FICO starting in 2026.
21 October 2025
··
Fair Isaac Corp’s 2025 Surge: How a Direct‑to‑Lender Move Disrupted Credit Bureaus and Re‑Energized FICO Stock

Credit-Score Shake-Up! FICO Stock Rockets 20% on Game-Changing Strategy

FICO shares surged up to 23% in early October 2025 after launching a direct licensing model for its credit scores, bypassing credit bureaus. Q3 revenue rose 20% to $536.4 million, with net income at $181.8 million. Equifax, Experian, and TransUnion stocks fell as analysts warned of profit hits. FICO’s market cap reached $46 billion, with a trailing P/E of 69.
3 October 2025
····
Wall Street Hits Record Highs as Tech Stocks Soar and Shutdown Worries Melt

Wall Street Hits Record Highs as Tech Stocks Soar and Shutdown Worries Melt

The Dow, S&P 500, and Nasdaq all closed at record highs on Oct. 2–3, led by gains in technology and AI stocks. Tesla fell 5% despite strong Q3 deliveries, while Stellantis jumped up to 8% on robust U.S. sales. A federal shutdown delayed key economic data, fueling bets on Fed rate cuts. OpenAI’s funding round implied a $500 billion valuation, boosting AI enthusiasm.
3 October 2025
············

Stock Market Today

  • Fluor's Russell Index Additions and Pharma Feasibility Studies Could Shift Investment Outlook
    June 29, 2026, 12:41 AM EDT. Fluor Corporation (NYSE: FLR) was added to multiple Russell growth indexes in June 2026, boosting its visibility in key equity benchmarks. Concurrently, it began feasibility studies for Voyageur Pharmaceuticals on an iodine project linked to Bayer and a new contrast media manufacturing facility in North America. These moves might broaden Fluor's market exposure beyond its traditional engineering and construction segments. While the developments support Fluor's backlog and diversification story, analysts caution the near-term focus remains on managing execution risks and cash flow volatility. Fluor projects $18.3 billion revenue and $443.4 million earnings by 2029, requiring steady growth amid potential cost and labor challenges. Investor opinions vary, with some seeing upside potential beyond current valuations, while others stress caution due to operational risks.

Latest articles

Trump-era loan caps could open door for private lenders in grad school market

Trump-era loan caps could open door for private lenders in grad school market

29 June 2026
July 1 federal loan caps slash Grad PLUS access, forcing many graduate and professional students to seek private loans; Sallie Mae projects up to 70% origination growth over several years, while SoFi reports record student-loan volume—investors now face a real-time test of how much demand shifts to private lenders as federal limits hit.
IREN Limited (NASDAQ:IREN) slides as Warriors badge faces AI revenue test

IREN Limited (NASDAQ:IREN) slides as Warriors badge faces AI revenue test

29 June 2026
IREN Limited (NASDAQ:IREN) plunged 21.3% to $47.21 over five straight down days despite announcing a record $50M+ annual Warriors jersey deal, as investors focused on the company’s not fully contracted $4.4B target ARR and high short interest at 19.74% of float, with Friday’s close near the lowest analyst target.
Go toTop